
Sign up to save your podcasts
Or


We discuss the promising phase I results of the Helios trial studying AXPAXLI TKI inhibitor implant for diabetic retinopathy with Dr. Dilsher Dhoot of California Retina Consultants.
By Retina Synthesis4.5
88 ratings
We discuss the promising phase I results of the Helios trial studying AXPAXLI TKI inhibitor implant for diabetic retinopathy with Dr. Dilsher Dhoot of California Retina Consultants.

43 Listeners

18 Listeners

100 Listeners

113,475 Listeners

56,978 Listeners

5 Listeners

9,559 Listeners

12 Listeners

47,440 Listeners

50 Listeners

12 Listeners

471 Listeners

19 Listeners

0 Listeners